Price
Senior Vice President & Chief Financial Officer
Psychiatry
Novelion Therapeutics
Macedonia
Biography
Michael Price holds a bachelor of science degree in business administration (accounting) from Auburn University and a master of business administration degree from Florida State University. Michael Price holds a bachelor of science degree in business administration (accounting) from Auburn University and a master of business administration degree from Florida State University.
Research Interest
Prior to Novelion, Michael Price was most recently vice president and chief financial officer for Noven Pharmaceuticals, Inc., a NASDAQ-listed company until its acquisition by Hisamitsu Pharmaceutical Company. Noven Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of prescription pharmaceutical products. In his role at Noven, Mr. Price was directly involved with the development and execution of strategy that scaled the Company's commercial organization and significantly increased revenues. Prior to Noven, Mr. Price was vice president, chief financial officer, treasurer, secretary and a member of the board of directors for Bentley Pharmaceuticals, a New York Stock Exchange-listed company until Teva Pharmaceutical Industries' 2008 acquisition. Mr. Price is a certified public accountant.